drugset / Trial / NCT00047190
Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial to study the effectiveness of tipifarnib in treating patients who have myelofibrosis with myeloid metaplasia. Tipifarnib may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth.
Timeline
- Start
- 2002-08
- Primary completion
- 2007-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tipifarnib | Small molecule | — | Oral |